RxDoctor Payments Data

Nathan Allen, DO

Family Medicine · Leon, IANPI 1629398987

Payments from drug & device makers

$568in general payments, 2019–2025

Across 33 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$178
  • Bayer$119
  • Pfizer$55
  • AbbVie$46
  • Lilly USA, LLC$36
  • Mylan Specialty L.p.$33
  • plus $101 from 6 others

What the payments were for

  • Food & beverage$54997%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$568 in reported general payments places this provider in the 75th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$37,424
Medicare patients
407
Services billed
1,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin280$238,131
OzempicSemaglutide146$161,929
EliquisApixaban203$150,504
BetaseronInterferon Beta-1b13$135,108
XareltoRivaroxaban135$111,529
FarxigaDapagliflozin Propanediol110$97,475
CopaxoneGlatiramer Acetate11$57,811
MounjaroTirzepatide39$42,058
TrulicityDulaglutide34$35,911
Tresiba Flextouch U-200Insulin Degludec56$33,378
Spiriva HandihalerTiotropium Bromide32$28,828
JanuviaSitagliptin Phosphate25$27,232
Tresiba Flextouch U-100Insulin Degludec42$26,916
Victoza 3-PakLiraglutide27$23,557
MyrbetriqMirabegron35$17,593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$178$259,406316 claims
PfizerEliquis, Abrysvo$55$155,632221 claims
BayerBetaseron$119$135,10813 claims
AstraZenecaFarxiga, Symbicort$16$106,769137 claims
Lilly USA, LLCMounjaro, Trulicity$36$77,96973 claims
Teva Pharmaceuticals USA, Inc.Copaxone$16$57,81111 claims
MerckJanuvia$24$27,23225 claims
NovartisEntresto$17$12,94315 claims
AbbVieLumigan, Combigan$46$12,25639 claims
Sanofi-aventis U.S. LLCLantus$17$5,27813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Leon

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →